Navigation Links
Thomson Reuters Launches Life Sciences Partner Ecosystem to Drive Collaborative R&D Drug Processes
Date:4/23/2012

PHILADELPHIA, April 23, 2012 /PRNewswire/ -- The Intellectual Property & Science division of Thomson Reuters, the world's leading source of intelligent information for businesses and professionals, today announced the launch of its Partner Ecosystem for the life sciences market, a new initiative aimed at enabling access to the company's life sciences information through application-specific solutions developed with third-party partners.

Through the Partner Ecosystem, third party developers take advantage of the Thomson Reuters Cortellis open architecture to access the company's content and technology, creating value-add custom solutions that meet the needs of their customers.  These solutions can include Thomson Reuters market leading ontologies, biological target information and other critical information that supports pharmaceutical business development and competitive intelligence projects.

The flexible approach to information delivery enables companies to integrate Thomson Reuters trusted drug pipeline data seamlessly into a user's workflow, delivering the right information at the point of need so users can make informed decisions more quickly.  In addition, partners gain access to the Cortellis Developer Center, a forum where client and third party developers collaborate to share ideas, best practices, and discuss new applications as well as obtain technical support from Thomson Reuters technology and content experts.

"We understand the important role our partners play in working with us to support the success of our mutual customers.  The Partner Ecosystem is a step toward providing the  infrastructure and collaboration environment necessary to develop solutions that enable the drug R&D process," said Jon Brett-Harris, executive vice president at Thomson Reuters. "The Partner Ecosystem, alongside our portfolio of other advanced solutions, provides the life sciences industry with the necessary tools and information to help address the challenges it faces."

The Partner Ecosystem web site for developers can be found at

http://cortellis.thomsonreuters.com/partners/. To become a partner, or for any questions, please send an email to Life.Sciences.Partners@thomsonreuters.com, or connect with Thomson Reuters at the Bio-IT World Conference & Expo, April 24-26, in Boston, Massachusetts, at booth 236.

Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for businesses and professionals. We combine industry expertise with innovative technology to deliver critical information to leading decision makers in the financial and risk, legal, tax and accounting, intellectual property and science and media markets, powered by the world's most trusted news organization. With headquarters in New York and major operations in London and Eagan, Minnesota, Thomson Reuters employs approximately 60,000 people and operates in over 100 countries. For more information, go to www.thomsonreuters.com.


'/>"/>
SOURCE Thomson Reuters
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. James Thomson receives 2008 Massry Prize honoring stem cell researchers
2. Clinical trial launches to see whether vitamin D helps treat multiple sclerosis
3. Elsevier launches new journal Algal Research
4. LABS, Inc. Launches Suite of Next-Generation Test Offerings; Focuses on Expanding Complex Biologic Testing Portfolio in 2012
5. PETA launches in silico testing resource to reduce number of animal tests
6. Cleveland Clinic Childrens Hospital launches study to genetically test for autism
7. Global Carbon Project launches UK office
8. Wiley-Blackwell launches 2 interdisciplinary review titles in developmental and membrane biology
9. Cell Press launches a new open-access journal, Cell Reports
10. AppTech Launches Cutting-Edge Age Recognition App for Mobile Marketing
11. ARVO launches new journal on translational research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/29/2016)... 29, 2016 BioDirection, a privately held medical ... the objective detection of concussion and other traumatic brain ... completed a meeting with the U.S. Food and Drug ... Pre-Submission Package. During the meeting company representatives reviewed plans ... precursor to commencement of a planned pilot trial. ...
(Date:11/28/2016)... "The biometric system market projected to ... system market is in the growth stage and is ... biometric system market is expected to be valued at ... 16.79% between 2016 and 2022. Government initiative in adoption ... rising use of biometric technology in financial institutes and ...
(Date:11/22/2016)... --  MedNet Solutions , an innovative SaaS-based eClinical technology ... is pleased to announce that the company has been ... Awards as "Most Outstanding in eClinical Solutions" for ... recognition and growth for MedNet, which has effectively supported ... iMedNet ™ , MedNet,s flagship eClinical technology ...
Breaking Biology News(10 mins):
(Date:12/7/2016)... 7, 2016 Neogen Corporation (NASDAQ: ... Dan Kephart as its chief science officer — ... his responsibilities at Neogen effective Jan. 1. ... the agribusiness unit of Thermo Fisher Scientific, as well ... Technologies. His extensive industry experience also includes the management ...
(Date:12/7/2016)... SAN DIEGO , Dec. 7, 2016  Biocom, the ... community, issued the statement below following passage of 21 st ... the House on November 30 by a 392-26 vote and ... This statement may be attributed to Joe Panetta , ... historic legislation that will give hope to millions of patients ...
(Date:12/7/2016)... 7, 2016  Muse bio, a privately-held company leading ... that Dr. Kevin Ness has been appointed ... Directors. Kevin succeeds Muse bio,s founding ... Chief Science Officer as well as remains Slade Professor, ... BioDesign Center at the RAS Energy Institute at the ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... pathology, announced today a new service to enable rapid migration of large pathology ... has remained one of the factors limiting adoption of digital pathology. Proscia’s free ...
Breaking Biology Technology: